|
|
||||||||||
|
|
|
|
|
|||||||
|
|
|
|
|
|||||||
|
|
|
|||||||||
|
|
|
|||||||||
|
|
|
|||||||||
|
|
||||||||||
|
|
|
|||||||||
|
|
|
|||||||||
|
|
||||||||||
|
|
||||||||||
|
|
||||||||||
|
|
||||||||||
|
|
||||||||||
|
|
||||||||||
|
|
||||||||||
|
|
||||||||||
CORPORATE SUPPORT
MAJOR SUPPORTERS
Abbott Virology
Boehringer Ingelheim International GMBH
Merck Sharp & Dohme
Tibotec
SUPPORTER
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
Monogram Biosciences, Inc
Pfizer Global Pharmaceuticals
Siemens Medical Solutions Diagnostics
Virco
CONTRIBUTORS
Pharmasset
Roche
Sequoia Pharmaceuticals, Inc.
Trimeris
GENERAL CONTRIBUTIONS
Schering-Plough Research Institute
Support Opportunities
Margie Poole
Secretariat, XVI International HIV Drug Resistance Workshop
Tel: +1 770 997 2484 ext 111
Fax: +1 770 997 2488
Email: mpoole@informedhorizons.com